47 results on '"Bregni, M."'
Search Results
2. ALLOGENEIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED RHABDOMYOSARCOMA: A RETROSPECTIVE ASSESSMENT: PH-AB118
3. GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM PERIPHERAL BLOOD FOR ADOPTIVE T-CELL TRANSFER IN COLORECTAL CANCER PATIENTS: WP-O024
4. GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM PERIPHERAL BLOOD OF COLORECTAL CANCER PATIENTS FOR ADOPTIVE T-CELL TRANSFER: PH-P060
5. PRESENTATION OF TWO CLINICAL PROTOCOLS OF HDC FOR BREAST CANCERS: WP-O023
6. GENERATION OF TUMOR-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FROM PERIPHERAL BLOOD OF COLORECTAL CANCER PATIENTS FOR ADOPTIVE T-CELL TRANSFER: WP-O026
7. THE ROLE OF MEGATHERAPY (MGT) AND STEM CELL TRANSPLANTATION (SCT) IN HIGH RISK EWING TUMOURS: MORE THAN 30 YEARS OF EBMT ACTIVITY.: PH-O100
8. Hematopoietic SCT in Europe: data and trends in 2011
9. Generation of tumour-specific cytotoxic T-lymphocytes from peripheral blood of colorectal cancer patients for adoptive t-cell transfer: O192
10. Is adoptive T-cell therapy for solid tumors coming of age?
11. The EBMT activity survey: 1990-2010
12. Combining allografting with mTOR inhibitors for metastatic renal cell cancer
13. No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients
14. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
15. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkinʼs lymphoma
16. Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting
17. High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomised metastatic breast cancer trials: O156
18. TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation
19. Adjuvant high-dose chemotherapy with autologous haematopoietic stem cell transplantation for breast cancer in Italy: 15-years results from the GITMO registry
20. Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting
21. High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 15 randomised adjuvant breast cancer trials
22. Matched unrelated donor stem cell transplantation for patients with diffuse large cell B cell lymphoma: a retrospective analysis of 118 patients registered through the European Group for Blood and Marrow Transplantation (EBMT)
23. Update of the results of high-dose chemotherapy as primary or salvage therapy in germ cell tumours
24. Allogeneic hematopoietic cell transplantation for metastatic breast cancer
25. Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
26. Current role of allogeneic stem cell transplantation in breast cancer
27. Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
28. The Second International Meeting on Allogeneic Transplantation in Solid Tumors
29. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
30. Haematopoietic stem cell transplantation in poor prognosis MDS and sAML: prolonged patients survival is achievable, but refining of infections management and reduction of treatment-related toxicities is required to improve patients outcome
31. Bone marrow mammaglobin expression as a marker of graft-versus-tumor effect after reduced-intensity allografting for advanced breast cancer
32. Effect of Age and Previous Autologous Transplantation on Nonrelapse Mortality and Survival in Patients Treated With Reduced-Intensity Conditioning and Allografting for Advanced Hematologic Malignancies
33. Primary tumour cells show specific susceptibility to KIR-incompatible NK cell-mediated lysis in an ex-vivo single cell cytotoxic assay by flow-cytometry
34. Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma
35. High-dose sequential chemotherapy with high-dose cytarabine and rituximab as salvage treatment in patients with relapse or refractory diffuse large B-cell lymphoma: a retrospective multicentre study on 52 patients
36. Family haplo-identical allogeneic stem cell transplantation for acute leukaemias: a survey on 273 adults patients on behalf of the Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
37. Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials
38. Foscarnet as single agent pre-emptive treatment of cytomegalovirus reactivation after T-cell depleted allogeneic haematopoietic stem cell transplantation
39. Donor lymphocyte infusion from HLA-matched siblings outside of the context of a haematopoietic stem cell transplantation: a pilot study
40. Morphologic and karyotypic analysis of bone marrow in 166 potential donors of hamatopoietic stem cells
41. Graft-versus-lymphoma effect in peripheral T-cell non-Hodgkin lymphomas after reduced-intensity conditioning followed by allogeneic transplantation
42. Bone marrow mammaglobin expression as a tool for assessing micrometastatic disease after reduced-intensity allografting for advanced breast cancer
43. Low transplant related mortality following allogeneic peripheral stem cell transplantation with reduced-intensity conditioning regimen in myelodysplastic syndrome and acute myeloid leukaemia from MDS: a prospective study from GITMO
44. Effect of age and previous autologous transplantation on treatment-related mortality and graft-versus-host disease in 110 patients treated with reduced-intensity conditioning and allografting for advanced haematological malignancies
45. Graft-versus-tumour effect following reduced-intensity allogeneic stem cell transplantation in renal cell cancer
46. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer
47. INTERIM RESULTS OF THE GROCTA 8 ADJUVANT TRIAL IN BREAST CANCER PATIENTS WITH TEN OR MORE INVOLVED NODES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.